Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay.

PubWeight™: 1.77‹?› | Rank: Top 3%

🔗 View Article (PMID 21407145)

Published in Pediatr Infect Dis J on August 01, 2011

Authors

María Catalina Pírez1, Gabriela Algorta, Alejandra Cedrés, Helena Sobrero, Adriana Varela, Gustavo Giachetto, Alicia Montano

Author Affiliations

1: Hospital Pediátrico, Centro Hospitalario Pereira Rossell, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay. mcpirez@yahoo.com

Articles citing this

Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial. PLoS Med (2014) 2.18

Pneumonia in low and middle income countries: progress and challenges. Thorax (2013) 1.21

Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants. Vaccine (2012) 0.90

Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay. PLoS One (2014) 0.85

Effect of pneumococcal conjugate vaccination in Uruguay, a middle-income country. PLoS One (2014) 0.80

Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis. Hum Vaccin Immunother (2016) 0.80

Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review. PLoS One (2015) 0.79

Indirect population impact of universal PCV7 vaccination of children in a 2 + 1 schedule on the incidence of pneumonia morbidity in Kielce, Poland. Eur J Clin Microbiol Infect Dis (2012) 0.78

Methods and challenges for the health impact assessment of vaccination programs in Latin America. Rev Saude Publica (2016) 0.77

Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination. Int J Mol Sci (2016) 0.77

Decrease in Hospitalizations for Pneumonia in Children under Five Years of Age in an Indian Reservation in Panama after the Introduction of the Heptavalent Pneumococcal Conjugate Vaccine (PCV7). Int J Pediatr (2013) 0.77

Decline in Child Hospitalization and Mortality After the Introduction of the 7-Valent Pneumococcal Conjugative Vaccine in Rwanda. Am J Trop Med Hyg (2016) 0.75

[Impact of antipneumococcal vaccination in Uruguay]. Rev Chilena Infectol (2011) 0.75

The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience. Hum Vaccin Immunother (2016) 0.75

Articles by these authors

Characterization of the RpoS status of clinical isolates of Salmonella enterica. Appl Environ Microbiol (2003) 1.12

Detection of intracellular bacterial communities in a child with Escherichia coli recurrent urinary tract infections. Pathog Dis (2013) 1.11

[Antibiotic consumption and antimicrobial susceptibility evolution in the Centro Hospitalario Pereira Rossell in methicillin resistant Staphylococcus aureus era]. Rev Chilena Infectol (2009) 1.08

Genomic and phenotypic variation in epidemic-spanning Salmonella enterica serovar Enteritidis isolates. BMC Microbiol (2009) 1.00

Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates in the paediatric hospital of Uruguay. J Antimicrob Chemother (2011) 0.98

Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay. Pediatr Infect Dis J (2014) 0.97

First human isolate of Salmonella enterica serotype Enteritidis harboring blaCTX-M-14 in South America. Antimicrob Agents Chemother (2012) 0.91

Random amplified polymorphic DNA and phenotyping analysis of Salmonella enterica serovar enteritidis isolates collected from humans and poultry in Uruguay from 1995 to 2002. J Clin Microbiol (2004) 0.89

Ampicillin and penicillin concentration in serum and pleural fluid of hospitalized children with community-acquired pneumonia. Pediatr Infect Dis J (2004) 0.84

Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies. Vaccine (2009) 0.83

Surveillance of antibiotic resistance evolution and detection of class 1 and 2 integrons in human isolates of multi-resistant Salmonella Typhimurium obtained in Uruguay between 1976 and 2000. Int J Infect Dis (2008) 0.80

[Pneumococcal invasive disease in newborns before and after 7-valent and 13-valent universal pneumococcal vaccination in Uruguay]. Rev Chilena Infectol (2015) 0.78

[Neonatal cholestasis and hypoglycemia like form of congenital hypopituitarism presentation]. Arch Argent Pediatr (2011) 0.76

[Neonatal cholestasis due to congenital toxoplasmosis. Case report]. Arch Argent Pediatr (2013) 0.76

[A strategy for the management of hospitalized children with acute lower respiratory infections]. Rev Saude Publica (2002) 0.75

Community-associated methicillin-resistant Staphylococcus aureus in children treated in Uruguay. J Infect Dev Ctries (2013) 0.75

Risk factors for the acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospitalized children. J Infect Dev Ctries (2013) 0.75

[Invasive Streptococcus pyogenes diseases 2005-2013: Pediatric Hospital Pereira Rossell Uruguay]. Rev Chilena Infectol (2014) 0.75

[Gentamicin pharmacokinetics in term newborn: ¿Is it necessary to systematically monitor plasmatic levels?]. Rev Chilena Infectol (2016) 0.75

[Treatment failure due to acquisition of antibiotic resistance: report of two clinical cases]. Rev Chilena Infectol (2013) 0.75

Pneumococcal Meningitis Before and After Universal Vaccination with Pneumococcal Conjugate Vaccines 7/13, Impact on Pediatric Hospitalization in Public and Non Public Institutions, in Uruguay. Pediatr Infect Dis J (2017) 0.75